Investor's Business Daily on MSN
Arcturus Crashes 50% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
Shares of Arcturus Therapeutics crashed more than 50% Wednesday on mixed test results for its experimental cystic fibrosis ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
Investor's Business Daily on MSN
Vertiv Crushes Q3 Estimates On Strong AI Data Center Business. But Stock Falls.
Data center infrastructure firm Vertiv beat expectations for the third quarter and guided above views for the current period.
Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025, and subsequently was awarded the FDA Commissioner’s National ...
Take-Two Interactive Software is expected to unveil its fiscal second-quarter earnings next month, and analysts project a ...
Diwali's festive glow masks a growing concern: colorectal cancer is increasingly striking young adults, a trend alarming ...
Good evening, and welcome to Raymond James Financial's Fiscal Fourth Quarter and Fiscal 2025 Earnings Call. This call is being recorded and will be available for replay on the company's Investor ...
India Today on MSN
Health Watch | Gut feeling: CSIR bets on microbes to heal chronic ills
What if your gut could hold the key to curing chronic disease? India’s premier science body, the Council of Scientific and ...
As we enter the final quarter of 2025, the fixed income landscape is shaped by slowing economic growth and the Federal ...
• Unlimited, exclusive journalism from our reporters and photographers on our websites and apps. • Opinions and reviews from columnists and critics. • Daily access to the digital e-Edition, an exact ...
Just 24 hours before the Lady Tigers’ 2025 Section IV, Class C playoff opener on Wednesday afternoon, senior Sophia Haney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results